Sudarshan Pharma Industries share news, announcements and annual reports
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹37.48.
30 Oct: open ₹39.04, high ₹39.29, low ₹34.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹927 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 1.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,84,31446.6% delivered
Sudarshan Pharma Industries share news and announcements
248 announcements, routine notices left out, newest first. Page 4 of 5.
Oct 2024
Sep 2024
24 Sep · Board meeting
Meeting on 30 Sep 2024: stock split
Aug 2024
Jul 2024
31 Jul · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1 Jul · Board meeting
Meeting on 4 Jul 2024: issue of warrants
Jun 2024
22 Jun · Announcement Under Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
May 2024
21 May · Board meeting
Meeting on 27 May 2024: audited results
Apr 2024
30 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
25 Apr · Certificate Pursuant To Reg. 40(9) & 40(10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.
20 Apr · Compliances-Compliance Certificate For The Period Ended March, 2024.
Mar 2024
22 Mar · Board meeting
Meeting on 28 Mar 2024
Feb 2024
Jan 2024
12 Jan · Business Update Of Sudarshan Pharma Industries Limited About The Event At CPHI 2023 (Convention On Pharmaceutical Ingredients). Success And Progress Of Which Resulted Into Receipt Of Huge Purchase Orders.
12 Jan · Business Update Of Sudarshan Pharma Industries Limited On Meeting Dr. William Selvamurthy And Dr. Tinku Basu At Amity University.
10 Jan · Announcement under Regulation 30 (LODR)-Meeting Updates
9 Jan · Announcement Under Regulation 30 Of SEBI LODR 2015
2 Jan · Announcement With Regards To Regulation 30 Of SEBI (LODR) Regulations 2015
Dec 2023
12 Dec · Board meeting
Meeting on 12 Dec 2023
Nov 2023
10 Nov · Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements), 2015.